Navigation Links
Leading Intellectual Property Counsel, James Kellerman, Joins Astellas as Vice President
Date:9/2/2014

NORTHBROOK, Ill., Sept. 2, 2014 /PRNewswire/ -- Astellas has appointed James Kellerman as the vice president of intellectual property (IP) in the Americas. Kellerman will report directly to Linda Friedman, senior vice president & general counsel at Astellas. In his new role, Kellerman will lead a team of patent attorneys to partner with the business and manage the region's intellectual property matters, coordinating closely with his global colleagues.

"I am very pleased to welcome Jim to Astellas. Jim brings a broad perspective of the industry and a breadth of pharmaceutical IP experience to his new position. He will be a strong leader for our IP group," said Friedman.

Kellerman has more than 25 years of broad IP and industry experience in the pharmaceutical industry as well as experience in other roles early in his career. For the past 11 years, Kellerman has worked at GlaxoSmithKline in the IP department in the US as well as in China. Prior to that he was the corporate intellectual property counsel for Sepracor Inc. Kellerman received his B.S. Pharmacy from the University of Cincinnati, College of Pharmacy and his law degree from the Franklin Pierce Law Center in Concord, New Hampshire.

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS.

Photo - http://photos.prnewswire.com/prnh/20140902/142153
Logo - http://photos.prnewswire.com/prnh/20140416/84970


'/>"/>
SOURCE Astellas
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China
2. FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database
3. Quanta Establishes Medical Advisory Board of World-Leading Renal Experts
4. Joel Sendek, Leading Wall Street Biotech Analyst, Joins Forward Pharma as Chief Financial Officer
5. 60+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Womens Most Common Form of Sexual Dysfunction, notes Even the Score
6. ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company
7. Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy
8. Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergans False And Misleading Statements
9. Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergans False and Misleading Statements
10. Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation
11. Clayton, Dubilier & Rice to Invest in PharMEDium, Nations Leading Provider of Sterile Compounding Services to Hospital Pharmacies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2017)... , June 30, 2017  AVACEN Medical (AVACEN) announced the publication ... research describes the use of its AVACEN Treatment Method ... from fibromyalgia. ... AVACEN Medical ... by chronic widespread pain. It affects approximately 200 to 400 million people ...
(Date:6/27/2017)...  Therapix Biosciences Ltd. (Nasdaq: TRPX ) ... development of cannabinoid-based drugs, today announced that the Company ... New York, NY on Wednesday, ... offering (IPO) of American Depository Shares (ADSs) listed on ... Dr. Elran Haber, Ph.D., Chief Executive Officer of Therapix, ...
(Date:6/20/2017)... and LAGUNA HILLS, Calif. , ... of new data that validate the use of MMprofiler ... patients with multiple myeloma (MM). In a poster presentation ... Hematology Association (EHA) in Madrid, Spain ... MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... July 24, 2017 , ... Right now, behind ... The agency is hammering out a game plan to implement changes and compromises ... to affect FDA-regulated firms. The new law:, ,     Seeks ways ...
(Date:7/24/2017)... ... 2017 , ... “A Short Walk to the Mailbox”: a remarkable memoir of ... published author, Ed Clark. Ed Clark is a church music director and choral ... minister of music and worship leader for over fifty years. He has a ...
(Date:7/23/2017)... , ... July 23, 2017 , ... A 20-year-long ... St. Louis, and led by the Minneapolis Veterans Administration Health Care System overwhelmingly supports ... the disease offers very few benefits. , In the cases involved with this ...
(Date:7/23/2017)... ... July 23, 2017 , ... “I Am Not Nothin’: The Serpent ... who could barely read and write and a brokenhearted young soldier who turned to ... of age novel about the power of simple faith is the work of published ...
(Date:7/22/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 22, ... ... surgeries take place each year with the majority of patients not requiring pain ... American Orthopaedic Society for Sports Medicine’s Annual Meeting today in Toronto, Ontario, ...
Breaking Medicine News(10 mins):